easystep cd138 + magnetic nanoparticles (STEMCELL Technologies Inc)
90
Structured Review
STEMCELL Technologies Inc
easystep cd138 + magnetic nanoparticles
Easystep Cd138 + Magnetic Nanoparticles, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/easystep+cd138+++magnetic+nanoparticles/human+cd138+positive+selection+kit/pmc06170385-144-6-13
Average 90 stars, based on 1 article reviews
Easystep Cd138 + Magnetic Nanoparticles, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/easystep+cd138+++magnetic+nanoparticles/human+cd138+positive+selection+kit/pmc06170385-144-6-13
Average 90 stars, based on 1 article reviews
easystep cd138 + magnetic nanoparticles - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells"
Article Title: YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells
Journal: Cell Death Discovery
doi: 10.1038/s41420-018-0108-8
Figure Legend Snippet: a Chemical structure of YL064. b U266 and MM1.S cells were treated with the indicated concentrations of YL064 for 24 h and apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, ## p < 0.01, compared with control annexin V+/PI+ cells. c U266 and MM1.S cells were untreated or treated with indicated concentrations of YL064 for 24 h. The indicated proteins were detected by western blot. d Primary CD138 + MM cells were treated with YL064 (20 μM) for 24 h and CD138 + apoptotic cells were evaluated by Annexin V/PI double-staining assay. ** p < 0.01, compared with control annexin V+/PI– cells, # p < 0.05, ## p < 0.01, compared with control annexin V+/PI+ cells. e Primary PBMCs cells from healthy donors were treated with the indicated concentrations of YL064 (40 μM) for 24 h and cell viability was evaluated by Trypan blue exclusion assay
Techniques Used: Double Staining, Control, Western Blot, Trypan Blue Exclusion Assay
Related Articles
Double Staining:Article Title: LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma Article Snippet: Article Title: MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway Article Snippet: Article Title: YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells Article Snippet: The CD138-positive cells were selected using EasyStep CD138 + magnetic nanoparticles from Article Title: cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance Article Snippet: CD138 + cells were isolated from MNCs using Control:Article Title: LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma Article Snippet: Article Title: MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway Article Snippet: Article Title: YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells Article Snippet: The CD138-positive cells were selected using EasyStep CD138 + magnetic nanoparticles from Article Title: cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance Article Snippet: CD138 + cells were isolated from MNCs using Western Blot:Article Title: LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma Article Snippet: Article Title: MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway Article Snippet: Article Title: YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells Article Snippet: The CD138-positive cells were selected using EasyStep CD138 + magnetic nanoparticles from Article Title: cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance Article Snippet: CD138 + cells were isolated from MNCs using Trypan Blue Exclusion Assay:Article Title: LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma Article Snippet: Article Title: MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway Article Snippet: Article Title: YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells Article Snippet: The CD138-positive cells were selected using EasyStep CD138 + magnetic nanoparticles from Article Title: cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance Article Snippet: CD138 + cells were isolated from MNCs using Isolation:Article Title: LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma Article Snippet: Article Title: MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway Article Snippet: Article Title: YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells Article Snippet: The CD138-positive cells were selected using EasyStep CD138 + magnetic nanoparticles from Article Title: cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance Article Snippet: CD138 + cells were isolated from MNCs using Staining:Article Title: LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma Article Snippet: Article Title: MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway Article Snippet: Article Title: YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells Article Snippet: The CD138-positive cells were selected using EasyStep CD138 + magnetic nanoparticles from Article Title: cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance Article Snippet: CD138 + cells were isolated from MNCs using Cell Culture:Article Title: LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma Article Snippet: Article Title: MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway Article Snippet: Article Title: YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells Article Snippet: The CD138-positive cells were selected using EasyStep CD138 + magnetic nanoparticles from Article Title: cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance Article Snippet: CD138 + cells were isolated from MNCs using Sedimentation:Article Title: LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma Article Snippet: Article Title: MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway Article Snippet: Article Title: YL064 directly inhibits STAT3 activity to induce apoptosis of multiple myeloma cells Article Snippet: The CD138-positive cells were selected using EasyStep CD138 + magnetic nanoparticles from Article Title: cAMP induces cell apoptosis in multiple myeloma and overcomes bortezomib resistance Article Snippet: CD138 + cells were isolated from MNCs using |